Year of launch: 1983
ISSN (print): 0736-6205 | ISSN (online): 1940-9818
Frequency: 12 issues per year – Impact Factor: 1.659 (2018)
Established in 1983, BioTechniques was founded on two ground-breaking and inspired principles:
First, and most critically, seeing the need for a journal to properly communicate methods, techniques and new instrumentation to those researchers working in the lab, BioTechniques was the first publication to feature peer-reviewed, primary research articles focused on methods and techniques – focusing not only on cutting edge methods and technologies, but also on those used in the ‘common lab’ on a day-to-day basis. As such, BioTechniques is not only read, but also used, by its audience at the bench.
The second transformational concept BioTechniques introduced was an open-access model of publishing – therefore being one of the first open access scholarly journals. This enabled wide distribution of content, initially as a print publication and now as a combined print and online proposition.
BioTechniques moves to Future Science Group
In January 2018 BioTechniques moved to Future Science Group.
Founded in 2001, Future Science Group is an independently owned publisher of journals and online resources, and conference organiser focused on niche areas of biomedicine. Key brands include, Oncology Central, Future Oncology, Bioanalysis Zone, Regenerative Medicine, Nanomedicine, Epigenomics and the Video Journal of Biomedicine.
Future Science Group supports the advancement of research, development and clinical practice by publishing high-quality journals and by using innovative tools to maximise the impact of the research published whilst providing solutions for enhancing communication and collaboration between researchers.